Immune deficient SCID mice support the hematopoietic development of su
rgically implanted human fetal thymus and bone. The usability of the r
esulting SCID-hu hematolymphoid chimaera as an assay system for human
candidate blood stem cells was suggested by the observation that allog
eneic CD34+ cells sorted from fetal liver and bone marrow can engraft
and differentiate in the transplanted human thymus and bone marrow. Th
e SCID-hu mouse has been further used, in combination with a mouse bon
e marrow stromal cell line that supports human myeloid and B lymphoid
differentiation in vitro, to identify a minor subset of fetal CD34-exp
ressing cells that exhibit multilineage hematopoietic potentialities.